切换至 "中华医学电子期刊资源库"

中华危重症医学杂志(电子版) ›› 2020, Vol. 13 ›› Issue (02) : 113 -117. doi: 10.3877/cma.j.issn.1674-6880.2020.02.007

所属专题: 文献

论著

联合检测D-二聚体和心锚重复蛋白在心房颤动合并急性脑梗塞中的诊断价值
张烨斐1,(), 童娅玲1, 陈乃云1, 丁晨彦1, 蒋磊2, 王晓巍2   
  1. 1. 310003 杭州,浙江大学医学院附属第一医院急诊科
    2. 322000 浙江金华,浙江大学医学院附属第四医院急诊医学科
  • 收稿日期:2020-01-01 出版日期:2020-04-01
  • 通信作者: 张烨斐
  • 基金资助:
    浙江省教育厅一般科研项目(N20140149); 浙江省医药卫生科技项目(2013KYB109)

Diagnostic value of combined detection of D-dimer and cardiac ankyrin repeat protein in atrial fibrillation complicated with acute cerebral infarction

Yefei Zhang1,(), Yaling Tong1, Naiyun Chen1, Chenyan Ding1, Lei Jiang2, Xiaowei Wang2   

  1. 1. Department of Emergency Medicine, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China
    2. Department of Emergency Medicine, the Fourth Affiliated Hospital, College of Medicine, Zhejiang University, 322000 Jinhua, China
  • Received:2020-01-01 Published:2020-04-01
  • Corresponding author: Yefei Zhang
  • About author:
    Corresponding author: Zhang Yefei, Email:
引用本文:

张烨斐, 童娅玲, 陈乃云, 丁晨彦, 蒋磊, 王晓巍. 联合检测D-二聚体和心锚重复蛋白在心房颤动合并急性脑梗塞中的诊断价值[J]. 中华危重症医学杂志(电子版), 2020, 13(02): 113-117.

Yefei Zhang, Yaling Tong, Naiyun Chen, Chenyan Ding, Lei Jiang, Xiaowei Wang. Diagnostic value of combined detection of D-dimer and cardiac ankyrin repeat protein in atrial fibrillation complicated with acute cerebral infarction[J]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2020, 13(02): 113-117.

目的

探索联合检测D-二聚体(DD)和心锚重复蛋白(CARP)在心房颤动(AF)合并急性脑梗塞(ACI)中的诊断价值。

方法

选取2014年10月至2016年10月就诊于浙江大学医学院附属第一医院或浙江大学医学院附属第四医院的AF或ACI患者为研究对象,其中单纯AF患者为AF组,单纯ACI患者为ACI组,AF合并ACI患者为AF + ACI组,每组各40例;同时选取同期体检中心40例健康体检者作为对照组。比较4组患者的血浆DD和CARP水平,并应用受试者工作特征(ROC)曲线判断DD、CARP和两者联合检测对诊断AF合并ACI的应用价值。

结果

4组患者的血浆DD和CARP水平比较,差异均有统计学意义(F = 25.874、12.474,P均< 0.001)。进一步两两比较,AF组、ACI组和AF + ACI组患者的DD水平均高于对照组[(0.53 ± 0.45)、(0.92 ± 0.60)、(1.00 ± 0.45)、(0.24 ± 0.11)mg/L,P均< 0.05],且ACI组和AF + ACI组均高于AF组(P均< 0.05)。同时,AF组和AF + ACI组患者的CARP水平均高于ACI组和对照组[(10 ± 5)、(11 ± 4)、(7 ± 4)、(6 ± 3)ng/L,P均< 0.05]。且联合检测DD和CARP对诊断AF合并ACI的应用价值优于单独检测DD(Z = 1.984,P = 0.047)或CARP(Z = 2.762,P = 0.006)。

结论

联合检测DD和CARP是诊断AF合并ACI的较好预测指标,具有临床指导价值。

Objective

To explore the diagnostic value of combined detection of D-dimer (DD) and cardiac ankyrin repeat protein (CARP) in atrial fibrillation (AF) patients complicated with acute cerebral infarction (ACI).

Methods

Forty AF patients, 40 ACI patients, and 40 AF patients complicated with ACI, admitted to the First Affiliated Hospital, College of Medicine, Zhejiang University or the Fourth Affiliated Hospital, College of Medicine, Zhejiang University from October 2014 to October 2016, were selected as the observation groups. Meanwhile, 40 healthy subjects taking the physical examination in our hospitals were selected as the control group. The plasma DD and CARP levels were determined and compared in the four groups. The receiver operating characteristic (ROC) curve was used to determine the value of DD, CARP and the combined indexes for the diagnosis of AF complicated with ACI.

Results

There were significant differences in the plasma DD and CARP levels among the four groups (F = 25.874, 12.474; both P < 0.001). Further pairwise comparison showed that the DD level was higher in the AF, ACI and AF + ACI groups than in the control group [(0.53 ± 0.45), (0.92 ± 0.60), (1.00 ± 0.45), (0.24 ± 0.11) mg/L; all P < 0.05], and it was higher in the ACI and AF + ACI groups than in the AF group (both P < 0.05). Meanwhile, the CARP level was higher in the AF and AF + ACI groups than in the ACI and control groups [(10 ± 5), (11 ± 4), (7 ± 4), (6 ± 3) ng/L; all P < 0.05]. The combined detection of DD and CARP was superior to the detection of DD (Z = 1.984, P = 0.047) or CARP (Z = 2.762, P = 0.006) alone in diagnosing AF complicated with ACI.

Conclusion

The combined detection of DD and CARP is more helpful in the diagnosis of AF complicated with ACI, with guiding value in clinical treatment.

表1 4组患者临床资料的比较(±s
图1 DD、CARP和两者联合检测对诊断AF合并ACI的ROC曲线分析图
[1]
Wang Z, Hu S, Sang S, et al. Age-period-cohort analysis of stroke mortality in China: data from the Global Burden of Disease Study 2013[J]. Stroke, 2017, 48 (2): 271-275.
[2]
Bevers MB, Kimberly WT. Critical care management of acute ischemic stroke[J]. Curr Treat Options Cardiovasc Med, 2017, 19 (6): 41.
[3]
Gooden JY, Powell BD, Akogyeram CO, et al. Recent advances in the pharmacological management of atrial fibrillation[J]. Am J Ther, 2016, 23 (1): e118-e138.
[4]
Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study[J]. Stroke, 1991, 22 (8): 983-988.
[5]
Danese E, Montagnana M, Cervellin G, et al. Hyper-coagulability, D-dimer and atrial fibrillation: an overview of biological and clinical evidence[J]. Ann Med, 2014, 46 (6): 364-371.
[6]
Chen CL, Lin JL, Lai LP, et al. Altered expression of FHL1, CARP, TSC-22 and P311 provide insights into complex transcriptional regulation in pacing-induced atrial fibrillation[J]. Biochim Biophys Acta, 2007, 1772 (3): 317-329.
[7]
January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society[J]. Circulation, 2014, 130 (23): e199-e267.
[8]
Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2013,44 (7): 2064-2089.
[9]
Zi WJ, Shuai J. Plasma D-dimer levels are associated with stroke subtypes and infarction volume in patients with acute ischemic stroke[J]. PLoS One, 2014, 9 (1): e86465.
[10]
Wang J, Ning R, Wang Y. Plasma D-dimer level, the promising prognostic biomarker for the acute cerebral infarction patients[J]. J Stroke Cerebrovasc Dis, 2016, 25 (8): 2011-2015.
[11]
Matsumoto M, Sakaguchi M, Okazaki S, et al. Relationship between plasma (D)-dimer level and cerebral infarction volume in patients with nonvalvular atrial fibrillation[J]. Cerebrovasc Dis, 2013, 35 (1): 64-72.
[12]
Feng D, D'Agostino RB, Silbershatz H, et al. Hemostatic state and atrial fibrillation (the Framingham Offspring Study)[J]. Am J Cardiol, 2001, 87 (2): 168-171.
[13]
Sadanaga T, Mitamura H, Fukuda K, et al. D-dimer levels positively correlate with B-type natriuretic peptide levels in patients with atrial fibrillation[J]. Int J Cardiol, 2012, 158 (1): 110-111.
[14]
Kim TW, Song IU, Chung SW, et al. Serum D-dimer levels are proportionally associated with left atrial enlargement in patients with an acute ischemic stroke due to non-valvular atrial fibrillation[J]. Intern Med, 2016, 55 (11): 1447-1452.
[15]
Krarup LH, Sandset EC, Sandset PM, et al. D-dimer levels and stroke progression in patients with acute ischemic stroke and atrial fibrillation[J]. Acta Neurol Scand, 2011, 124 (1): 40-44.
[16]
Wang W, Zhu Y, Yi J, et al. Nkx2.5/CARP signaling pathway contributes to the regulation of ion channel remodeling induced by rapid pacing in rat atrial myocytes[J]. Mol Med Rep, 2016, 14 (4): 3848-3854.
[17]
黄晓娇,陈漠水,任良强,等.心房颤动患者血清心锚重复蛋白的变化及临床意义[J].临床心血管病杂志,2012,28(1):54-56.
[1] 刘丹妮, 敖梦, 冉海涛, 李世玉, 秦芳. 三维超声心动图及二维斑点追踪成像对持续性心房颤动复律后双心房逆向重构的评估[J]. 中华医学超声杂志(电子版), 2023, 20(08): 827-835.
[2] 郑雨萌, 丁明岩, 孙丹丹, 郭丽娟, 张慧慧, 赵含章, 朱芳. 超声心动图对非瓣膜性心房颤动患者左心房及左心耳功能的评价及血栓形成预测因素分析[J]. 中华医学超声杂志(电子版), 2023, 20(02): 207-212.
[3] 张忆雪, 陈漠水, 张福伟, 郑颖, 孙定军, 叶青妃. 贝那普利通过下调心锚重复蛋白改善心肌梗死后心肌重塑[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 292-299.
[4] 吴庆华, 冒勇, 闫效坤. AECOPD并发AKI的危险因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 529-531.
[5] 张沥, 宋俊华, 何皓, 杨雪瑶, 周康. 血清D-D、PAI-1、sICAM-1水平与糖尿病合并肺部感染病情严重程度及预后的关系[J]. 中华肺部疾病杂志(电子版), 2023, 16(02): 203-205.
[6] 石晓璟, 苏晓乐, 王利华. 直接口服抗凝药在慢性肾脏病合并心房颤动患者中的应用[J]. 中华肾病研究电子杂志, 2023, 12(01): 26-31.
[7] 王青磊, 李伟, 董慧文, 刘海玲, 王博, 孟祥玲, 冯亚斌. 低管电压扫描联合低剂量造影剂在肺静脉及左心房造影中的价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(02): 89-92.
[8] 王震, 杨晓月, 苏康康, 王朝阳, 李少杰, 陈淑霞, 谷剑. β受体阻滞剂对心力衰竭合并房颤患者预后影响的研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(04): 479-482.
[9] 王振东, 李赟, 姜灵凯, 王婷, 刘洋. 心脏瓣膜术同期行房颤射频消融术及左心耳夹闭术预防心源性脑卒中的临床研究[J]. 中华临床医师杂志(电子版), 2023, 17(02): 142-148.
[10] 段园霞, 顾柳娜, 张磊, 周丽婷, 朱海瀛, 杨超, 陈海英, 顾晓青, 高宗尚, 黄蛟灵. 上海市奉贤区基层全科医师对心房颤动的认知现状及影响因素分析[J]. 中华心脏与心律电子杂志, 2023, 11(03): 154-159.
[11] 曹宾, 郭瑛, 夏盼盼, 刘佳榛, 王骏, 孙育民. 非阵发性心房颤动的治疗策略:来自心脏电生理一线医师的问卷调查[J]. 中华心脏与心律电子杂志, 2023, 11(03): 147-153.
[12] 范家宁, 林大卫, 李明飞, 张峰, 张晓春, 潘文志, 周达新. 左心耳封堵术联合房间隔缺损封堵术一站式手术安全性与有效性研究[J]. 中华心脏与心律电子杂志, 2023, 11(02): 109-113.
[13] 蒋子涵, 于丰源, 张宏达, 丁蕾, 米利杰, 唐闽. 2023年美国心律学年会心律失常领域最新临床研究进展[J]. 中华心脏与心律电子杂志, 2023, 11(02): 125-128.
[14] 党梦秋, 范嘉祺, 戴晗怡, 陈俊, 李然犀, 徐建国, 李程, 郭宇超, 刘先宝, 王建安. 智能手表对主动脉瓣置换术后患者心房颤动及左束支传导阻滞的诊断价值[J]. 中华心脏与心律电子杂志, 2023, 11(01): 24-27.
[15] 邱令智, 胡萍, 罗婷, 鄢华. 脂蛋白(a)与心房颤动关系的研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(03): 280-284.
阅读次数
全文


摘要